Logo image of CTXR

CITIUS PHARMACEUTICALS INC (CTXR) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:CTXR - US17322U3068 - Common Stock

0.8264 USD
+0.03 (+3.3%)
Last: 1/22/2026, 2:17:39 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CTXR revenue by date.CTXR revenue by date.
N/AN/A
147.57%
N/A
50.28%
N/A
21.50%
N/A
14.50%
N/A
13.35%
N/A
-31.28%
N/A
5.57%
EBITDA
YoY % growth
CTXR ebitda by date.CTXR ebitda by date.
N/A-7.45M-9.99M
-34.09%
-13.79M
-38.04%
-15.6M
-13.13%
-17.71M
-13.53%
-23.54M
-32.92%
-33.32M
-41.55%
-36.729M
-10.23%
-41.994M
-14.33%
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CTXR ebit by date.CTXR ebit by date.
-3.23M-7.45M
-130.65%
-9.99M
-34.09%
-13.79M
-38.04%
-15.6M
-13.13%
-17.71M
-13.53%
-23.54M
-32.92%
-33.32M
-41.55%
-36.732M
-10.24%
-41.996M
-14.33%
-38.526M
8.26%
N/A
143.59%
N/A
464.71%
N/A
58.60%
N/A
26.58%
N/A
17.21%
N/A
15.57%
N/A
-28.49%
N/A
6.58%
Operating Margin
CTXR operating margin by date.CTXR operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CTXR eps by date.CTXR eps by date.
N/AN/AN/AN/A-0.78
98.05%
-11.50
-1,374.36%
-6.75
41.30%
-5.50
18.52%
N/A
25.82%
-5.84
-43.19%
-4.09
29.99%
N/A
147.38%
N/A
63.16%
N/A
-12.26%
N/A
14.34%
N/A
4.50%
N/A
8.92%
N/A
3.67%
N/A
3.27%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.01
99.22%
-0.20
83.94%
-0.01
98.73%
-0.37
49.00%
0.33
3,300.00%
0.34
265.00%
0.37
3,700.00%
0.38
202.78%
Revenue
Q2Q % growth
3.524M10.068M15.102M18.667M41.071M
1,065.47%
42.856M
325.67%
46.428M
207.43%
48.213M
158.28%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-9.049M
9.86%
-4.649M
58.71%
-1.891M
78.48%
-558.96K
93.38%
17.498M
293.36%
18.259M
492.74%
19.781M
1,146.02%
20.541M
3,774.86%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2025
Q2Q % growth
-0.72
54.77%
-0.50-0.22-45.04%
Q3 2025
Q2Q % growth
-0.80
46.67%
-0.60-0.20-32.93%
Q2 2025
Q2Q % growth
-1.27
-1.60%
-0.39-0.88-224.81%
Q1 2025
Q2Q % growth
-1.30
13.33%
-0.59-0.71-121.01%
Q4 2024
Q2Q % growth
-1.59
20.40%
-1.53-0.06-4.05%
Q3 2024
Q2Q % growth
-1.50 -1.28-0.23-17.65%
Q2 2024
Q2Q % growth
-1.25
28.57%
-1.530.2818.30%
Q1 2024
Q2Q % growth
-1.50 3.32-4.81-145.25%
Q4 2023
Q2Q % growth
-2.00
-60.00%
-0.51-1.49-292.16%
Q3 2023
Q2Q % growth
-1.50 -1.40-0.10-6.95%
Q2 2023
Q2Q % growth
-1.75
-40.00%
-0.89-0.86-96.08%
Q4 2022
Q2Q % growth
-1.25
-150.00%
-1.02-0.23-22.55%
Q3 2022
Q2Q % growth
-1.50 -1.28-0.23-17.65%
Q2 2022
Q2Q % growth
-1.25
-25.00%
-1.790.5429.97%
Q1 2022
Q2Q % growth
-1.50
60.00%
-1.530.031.96%
Q4 2021
Q2Q % growth
-0.50
71.43%
-1.020.5250.98%
Q3 2021
Q2Q % growth
-1.50
45.45%
-1.660.169.50%
Q2 2021
Q2Q % growth
-1.00
69.23%
-1.910.9147.71%
Q1 2021
Q2Q % growth
-3.75 4.08-7.83-191.91%
Q4 2020
Q2Q % growth
-1.75 -2.680.9334.64%
Q3 2020
Q2Q % growth
-2.75 -2.68-0.07-2.71%
Q2 2020
Q2Q % growth
-3.25 -2.55-0.70-27.45%
Q1 2020
Q2Q % growth
-3.75 -3.57-0.18-5.04%
CTXR Yearly EPS VS EstimatesCTXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -10 -20 -30 -40
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2025
Q2Q % growth
5.871M-5.871M-100.00%
Q3 2025
Q2Q % growth
4.405M-4.405M-100.00%
Q2 2025
Q2Q % growth
2.721M-2.721M-100.00%
Q1 2025
Q2Q % growth
7.202M-7.202M-100.00%
Q1 2024
Q2Q % growth
21.721M-21.721M-100.00%
Q1 2021
Q2Q % growth
19.154M-19.154M-100.00%
CTXR Yearly Revenue VS EstimatesCTXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 427.78% 427.78%
Revenue0% 0% 0% 0%